Dipyridamole potentiates adriamycin cytotoxicity by a mechanism other than inhibiting nucleoside uptake

H. Kusumoto, Y. Maehara, H. Anai, R. Kumashiro, K. Sugimachi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Nitrobenzylthioinosine (NBTI) and dipyridamole (DP) are competitive inhibitors of cellular nucleoside uptake. Although combined treatment of HeLa cells with adriamycin (ADM) and DP enhanced ADM cytotoxicity in cell growth and clonogenic assays, the combination of ADM and noncytostatic levels (less than 1 μM) of NBTI did not change the cytotoxic potential of ADM in vitro. DP enhanced the inhibition of clonogenicity by ADM, even in nucleoside-enriched mediums. These results suggest that the synergy between ADM and DP was hardly due to the inhibition of nucleoside uptake by DP, but was due to the enhancement of intracellular ADM accumulation by DP.

Original languageEnglish
Pages (from-to)1539-1542
Number of pages4
JournalAnticancer research
Volume11
Issue number4
Publication statusPublished - Jan 1 1991

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kusumoto, H., Maehara, Y., Anai, H., Kumashiro, R., & Sugimachi, K. (1991). Dipyridamole potentiates adriamycin cytotoxicity by a mechanism other than inhibiting nucleoside uptake. Anticancer research, 11(4), 1539-1542.